APO Research
Talk to an analyst

APO RESEARCH · REPORT

Home Neuromodulation Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Home Neuromodulation Device Market Outlook and Growth Opportunities 2026

24 December 2025190 pages

Choose your research edition.

Industry ResearchHome Neuromodulation Device Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Home Neuromodulation Device Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Home Neuromodulation Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Home Neuromodulation Device Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Home Neuromodulation Device Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Home Neuromodulation Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Home Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Home Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Home Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Home Neuromodulation Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Home Neuromodulation Device market include NeuroSky, Emotiv, Thync, Muse and Halo Neuroscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Home Neuromodulation Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Home Neuromodulation Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Home Neuromodulation Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Home Neuromodulation Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Home Neuromodulation Device Segment by Company

NeuroSky

Emotiv

Thync

Muse

Halo Neuroscience

Home Neuromodulation Device Segment by Type

Brainwave Monitoring Equipment

Brain-Computer Interface Device

Neurofeedback Device

Others

Home Neuromodulation Device Segment by Application

Aldult

Child

Home Neuromodulation Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Home Neuromodulation Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Home Neuromodulation Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Home Neuromodulation Device significant trends, drivers, influence factors in global and regions.

6. To analyze Home Neuromodulation Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Neuromodulation Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Home Neuromodulation Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Neuromodulation Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Home Neuromodulation Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Home Neuromodulation Device industry.

Chapter 3: Detailed analysis of Home Neuromodulation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Home Neuromodulation Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Home Neuromodulation Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Home Neuromodulation Device Industry Trends Table 2. Home Neuromodulation Device Industry Drivers Table 3. Home Neuromodulation Device Industry Opportunities and Challenges Table 4. Home Neuromodulation Device Industry Restraints Table 5. Global Home Neuromodulation Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Home Neuromodulation Device Revenue Share by Company (2021-2026) Table 7. Global Home Neuromodulation Device Sales Volume by Company (Units) & (2021-2026) Table 8. Global Home Neuromodulation Device Sales Volume Share by Company (2021-2026) Table 9. Global Home Neuromodulation Device Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Home Neuromodulation Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Home Neuromodulation Device Key Company Manufacturing Base & Headquarters Table 12. Global Home Neuromodulation Device Company, Product Type & Application Table 13. Global Home Neuromodulation Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Home Neuromodulation Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Brainwave Monitoring Equipment Table 18. Significant Companies of Brain-Computer Interface Device Table 19. Significant Companies of Neurofeedback Device Table 20. Significant Companies of Others Table 21. Global Home Neuromodulation Device Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 22. Global Home Neuromodulation Device Sales Volume by Type (2021-2026) & (Units) Table 23. Global Home Neuromodulation Device Sales Volume by Type (2027-2032) & (Units) Table 24. Global Home Neuromodulation Device Sales Volume Share by Type (2021-2026) Table 25. Global Home Neuromodulation Device Sales Volume Share by Type (2027-2032) Table 26. Global Home Neuromodulation Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Home Neuromodulation Device Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Home Neuromodulation Device Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Home Neuromodulation Device Sales Value Share by Type (2021-2026) Table 30. Global Home Neuromodulation Device Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Aldult Table 32. Significant Companies of Child Table 33. Global Home Neuromodulation Device Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 34. Global Home Neuromodulation Device Sales Volume by Application (2021-2026) & (Units) Table 35. Global Home Neuromodulation Device Sales Volume by Application (2027-2032) & (Units) Table 36. Global Home Neuromodulation Device Sales Volume Share by Application (2021-2026) Table 37. Global Home Neuromodulation Device Sales Volume Share by Application (2027-2032) Table 38. Global Home Neuromodulation Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Home Neuromodulation Device Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Home Neuromodulation Device Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Home Neuromodulation Device Sales Value Share by Application (2021-2026) Table 42. Global Home Neuromodulation Device Sales Value Share by Application (2027-2032) Table 43. Global Home Neuromodulation Device Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 44. Global Home Neuromodulation Device Sales by Region (2021-2026) & (Units) Table 45. Global Home Neuromodulation Device Sales Market Share by Region (2021-2026) Table 46. Global Home Neuromodulation Device Sales by Region (2027-2032) & (Units) Table 47. Global Home Neuromodulation Device Sales Market Share by Region (2027-2032) Table 48. Global Home Neuromodulation Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Home Neuromodulation Device Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Home Neuromodulation Device Sales Value Share by Region (2021-2026) Table 51. Global Home Neuromodulation Device Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Home Neuromodulation Device Sales Value Share by Region (2027-2032) Table 53. Global Home Neuromodulation Device Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Home Neuromodulation Device Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Home Neuromodulation Device Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Global Home Neuromodulation Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Home Neuromodulation Device Sales by Country (2021-2026) & (Units) Table 58. Global Home Neuromodulation Device Sales Market Share by Country (2021-2026) Table 59. Global Home Neuromodulation Device Sales by Country (2027-2032) & (Units) Table 60. Global Home Neuromodulation Device Sales Market Share by Country (2027-2032) Table 61. Global Home Neuromodulation Device Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Home Neuromodulation Device Sales Value Market Share by Country (2021-2026) Table 63. Global Home Neuromodulation Device Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Home Neuromodulation Device Sales Value Market Share by Country (2027-2032) Table 65. NeuroSky Company Information Table 66. NeuroSky Business Overview Table 67. NeuroSky Home Neuromodulation Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. NeuroSky Home Neuromodulation Device Product Portfolio Table 69. NeuroSky Recent Development Table 70. Emotiv Company Information Table 71. Emotiv Business Overview Table 72. Emotiv Home Neuromodulation Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Emotiv Home Neuromodulation Device Product Portfolio Table 74. Emotiv Recent Development Table 75. Thync Company Information Table 76. Thync Business Overview Table 77. Thync Home Neuromodulation Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Thync Home Neuromodulation Device Product Portfolio Table 79. Thync Recent Development Table 80. Muse Company Information Table 81. Muse Business Overview Table 82. Muse Home Neuromodulation Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Muse Home Neuromodulation Device Product Portfolio Table 84. Muse Recent Development Table 85. Halo Neuroscience Company Information Table 86. Halo Neuroscience Business Overview Table 87. Halo Neuroscience Home Neuromodulation Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Halo Neuroscience Home Neuromodulation Device Product Portfolio Table 89. Halo Neuroscience Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. Home Neuromodulation Device Distributors List Table 93. Home Neuromodulation Device Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Home Neuromodulation Device Product Image Figure 2. Global Home Neuromodulation Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Home Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Home Neuromodulation Device Sales (2021-2032) & (Units) Figure 5. Global Home Neuromodulation Device Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Home Neuromodulation Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Brainwave Monitoring Equipment Image Figure 10. Brain-Computer Interface Device Image Figure 11. Neurofeedback Device Image Figure 12. Others Image Figure 13. Global Home Neuromodulation Device Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Home Neuromodulation Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Home Neuromodulation Device Sales Volume Share by Type (2021-2032) Figure 16. Global Home Neuromodulation Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Home Neuromodulation Device Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Home Neuromodulation Device Sales Value Share by Type (2021-2032) Figure 19. Aldult Image Figure 20. Child Image Figure 21. Global Home Neuromodulation Device Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 22. Global Home Neuromodulation Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Home Neuromodulation Device Sales Volume Share by Application (2021-2032) Figure 24. Global Home Neuromodulation Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Home Neuromodulation Device Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Home Neuromodulation Device Sales Value Share by Application (2021-2032) Figure 27. Global Home Neuromodulation Device Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 28. Global Home Neuromodulation Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Home Neuromodulation Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Home Neuromodulation Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Home Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 32. North America Home Neuromodulation Device Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Home Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Home Neuromodulation Device Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Home Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Home Neuromodulation Device Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Home Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 38. South America Home Neuromodulation Device Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Home Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Home Neuromodulation Device Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Home Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Home Neuromodulation Device Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Home Neuromodulation Device Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Brainwave Monitoring Equipment
  • Brain-Computer Interface Device
  • Neurofeedback Device
  • Others
Applications
  • Aldult
  • Child
Companies covered
  • NeuroSky
  • Emotiv
  • Thync
  • Muse
  • Halo Neuroscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Home Neuromodulation Device Sales Value (2021-2032)
  4. 1.2.2 Global Home Neuromodulation Device Sales Volume (2021-2032)
  5. 1.2.3 Global Home Neuromodulation Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Home Neuromodulation Device Market Dynamics
  1. 2.1 Home Neuromodulation Device Industry Trends
  2. 2.2 Home Neuromodulation Device Industry Drivers
  3. 2.3 Home Neuromodulation Device Industry Opportunities and Challenges
  4. 2.4 Home Neuromodulation Device Industry Restraints
3 Home Neuromodulation Device Market by Company
  1. 3.1 Global Home Neuromodulation Device Company Revenue Ranking in 2025
  2. 3.2 Global Home Neuromodulation Device Revenue by Company (2021-2026)
  3. 3.3 Global Home Neuromodulation Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Home Neuromodulation Device Average Price by Company (2021-2026)
  5. 3.5 Global Home Neuromodulation Device Company Ranking (2024-2026)
  6. 3.6 Global Home Neuromodulation Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Home Neuromodulation Device Company Product Type and Application
  8. 3.8 Global Home Neuromodulation Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Home Neuromodulation Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Home Neuromodulation Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Home Neuromodulation Device Market by Type
  1. 4.1 Home Neuromodulation Device Type Introduction
  2. 4.1.1 Brainwave Monitoring Equipment
  3. 4.1.2 Brain-Computer Interface Device
  4. 4.1.3 Neurofeedback Device
  5. 4.1.4 Others
  6. 4.2 Global Home Neuromodulation Device Sales Volume by Type
  7. 4.2.1 Global Home Neuromodulation Device Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Home Neuromodulation Device Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Home Neuromodulation Device Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Home Neuromodulation Device Sales Value by Type
  11. 4.3.1 Global Home Neuromodulation Device Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Home Neuromodulation Device Sales Value by Type (2021-2032)
  13. 4.3.3 Global Home Neuromodulation Device Sales Value Share by Type (2021-2032)
5 Home Neuromodulation Device Market by Application
  1. 5.1 Home Neuromodulation Device Application Introduction
  2. 5.1.1 Aldult
  3. 5.1.2 Child
  4. 5.2 Global Home Neuromodulation Device Sales Volume by Application
  5. 5.2.1 Global Home Neuromodulation Device Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Home Neuromodulation Device Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Home Neuromodulation Device Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Home Neuromodulation Device Sales Value by Application
  9. 5.3.1 Global Home Neuromodulation Device Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Home Neuromodulation Device Sales Value by Application (2021-2032)
  11. 5.3.3 Global Home Neuromodulation Device Sales Value Share by Application (2021-2032)
6 Home Neuromodulation Device Regional Sales and Value Analysis
  1. 6.1 Global Home Neuromodulation Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Home Neuromodulation Device Sales by Region (2021-2032)
  3. 6.2.1 Global Home Neuromodulation Device Sales by Region: 2021-2026
  4. 6.2.2 Global Home Neuromodulation Device Sales by Region (2027-2032)
  5. 6.3 Global Home Neuromodulation Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Home Neuromodulation Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Home Neuromodulation Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Home Neuromodulation Device Sales Value by Region (2027-2032)
  9. 6.5 Global Home Neuromodulation Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Home Neuromodulation Device Sales Value (2021-2032)
  12. 6.6.2 North America Home Neuromodulation Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Home Neuromodulation Device Sales Value (2021-2032)
  15. 6.7.2 Europe Home Neuromodulation Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Home Neuromodulation Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Home Neuromodulation Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Home Neuromodulation Device Sales Value (2021-2032)
  21. 6.9.2 South America Home Neuromodulation Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Home Neuromodulation Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Home Neuromodulation Device Sales Value Share by Country, 2025 VS 2032
7 Home Neuromodulation Device Country-level Sales and Value Analysis
  1. 7.1 Global Home Neuromodulation Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Home Neuromodulation Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Home Neuromodulation Device Sales by Country (2021-2032)
  4. 7.3.1 Global Home Neuromodulation Device Sales by Country (2021-2026)
  5. 7.3.2 Global Home Neuromodulation Device Sales by Country (2027-2032)
  6. 7.4 Global Home Neuromodulation Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Home Neuromodulation Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Home Neuromodulation Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Home Neuromodulation Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Home Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Home Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 NeuroSky
  2. 8.1.1 NeuroSky Company Information
  3. 8.1.2 NeuroSky Business Overview
  4. 8.1.3 NeuroSky Home Neuromodulation Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 NeuroSky Home Neuromodulation Device Product Portfolio
  6. 8.1.5 NeuroSky Recent Developments
  7. 8.2 Emotiv
  8. 8.2.1 Emotiv Company Information
  9. 8.2.2 Emotiv Business Overview
  10. 8.2.3 Emotiv Home Neuromodulation Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Emotiv Home Neuromodulation Device Product Portfolio
  12. 8.2.5 Emotiv Recent Developments
  13. 8.3 Thync
  14. 8.3.1 Thync Company Information
  15. 8.3.2 Thync Business Overview
  16. 8.3.3 Thync Home Neuromodulation Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Thync Home Neuromodulation Device Product Portfolio
  18. 8.3.5 Thync Recent Developments
  19. 8.4 Muse
  20. 8.4.1 Muse Company Information
  21. 8.4.2 Muse Business Overview
  22. 8.4.3 Muse Home Neuromodulation Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Muse Home Neuromodulation Device Product Portfolio
  24. 8.4.5 Muse Recent Developments
  25. 8.5 Halo Neuroscience
  26. 8.5.1 Halo Neuroscience Company Information
  27. 8.5.2 Halo Neuroscience Business Overview
  28. 8.5.3 Halo Neuroscience Home Neuromodulation Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Halo Neuroscience Home Neuromodulation Device Product Portfolio
  30. 8.5.5 Halo Neuroscience Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Home Neuromodulation Device Value Chain Analysis
  2. 9.1.1 Home Neuromodulation Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Home Neuromodulation Device Sales Mode & Process
  6. 9.2 Home Neuromodulation Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Home Neuromodulation Device Distributors
  9. 9.2.3 Home Neuromodulation Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst